The trial does not establish anti-aging or hair-growth benefits, a morning-versus-night advantage, long-term cosmetic frequency, or an injectable protocol
When concentrated A2M is injected into osteoarthritic joints, it halts the progression of the disease and initiates cartilage repair and regeneration
Saint-Germain, E., Mignacca, L., Vernier, M., Bobbala, D., Ilangumaran, S., & Ferbeyre, G
Sites with adequate subcutaneous tissue depth produce the least discomfort
Optimized volume/price ratio, extended autonomy (several weeks at typical 250-500 mcg dose), final concentration adjustable to protocol (5 mg/ml with 2 ml bacteriostatic, or 2.5 mg/ml with 4 ml for finer dosing)